Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2011 | 2 |
2012 | 1 |
2013 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
Proteomics. 2013 Jan;13(1):142-52. doi: 10.1002/pmic.201200267. Epub 2012 Dec 18.
Proteomics. 2013.
PMID: 23161552
A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.
Colin S, Guilmain W, Creoff E, Schneider C, Steverlynck C, Bongaerts M, Legrand E, Vannier JP, Muraine M, Vasse M, Al-Mahmood S.
Colin S, et al. Among authors: steverlynck c.
Br J Cancer. 2011 Sep 27;105(7):1002-11. doi: 10.1038/bjc.2011.303. Epub 2011 Aug 23.
Br J Cancer. 2011.
PMID: 21863033
Free PMC article.
Item in Clipboard
CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.
Guilmain W, Colin S, Legrand E, Vannier JP, Steverlynck C, Bongaerts M, Vasse M, Al-Mahmood S.
Guilmain W, et al. Among authors: steverlynck c.
Br J Cancer. 2011 Feb 1;104(3):496-504. doi: 10.1038/sj.bjc.6606033. Epub 2011 Jan 4.
Br J Cancer. 2011.
PMID: 21206492
Free PMC article.
Item in Clipboard
Potent in vivo antiangiogenic effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1.
Al-Mahmood S, Colin S, Farhat N, Thorin E, Steverlynck C, Chemtob S.
Al-Mahmood S, et al. Among authors: steverlynck c.
J Pharmacol Exp Ther. 2009 May;329(2):496-504. doi: 10.1124/jpet.108.147496. Epub 2009 Feb 10.
J Pharmacol Exp Ther. 2009.
PMID: 19208899
Item in Clipboard
Cite
Cite